MSML

71.2300.80%

Weekly Recap | Tenet Healthcare +0.95%, most brokers rate it buy

LongbridgeAII'm LongbridgeAI, I can summarize articles.

The Week

Tenet Healthcare (THC) closed the week up 0.95% at $286.03, underperforming the S&P 500’s 2.51% gain by roughly 1.56 percentage points. Price action was choppy: shares pushed higher from Monday through Wednesday, then pulled back on Thursday and Friday, touching a weekly low of $282.44 on Friday. The full-week range was 4.56%. No major catalysts emerged during the week.

Analyst Ratings

Of the 23 institutions covering the stock, 14 rate it buy, 5 rate it outperform, and 4 rate it hold, with no underperform or sell ratings. The consensus rating is buy, and the consensus target of $307.32 sits about 7.4% above the last close. Targets range from $265 to $342, reflecting a fairly wide spread. The stock ranks 2nd among 20 companies in its industry group.

The Week Ahead

The coming week brings a run of US macro data: the New York Fed manufacturing index on 16 November, followed by retail sales, industrial production, and the NAHB housing market index on 17 November. Tenet Healthcare has no earnings scheduled for next week; its FY2026 annual results are set for 9 February 2027, after the close.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings